Medinews - Medical News, Articles and Blogs

Advertisement
Memory Pharmaceuticals Corp. (Nasdaq: MEMY) today announced that it has completed enrollment in its ongoing Phase 2a trial of MEM 1003 in patients with acute mania in bipolar disorder. The Company now expects to report top-line results in the first quarter of 2007. [click link for full article] read more »
Source:http://www.medicalnewstoday.com
Discuss   Bury
Researchers have identified a common gene variant that more than doubles the risk of autism. The research, led by investigators at the Vanderbilt Kennedy Center for Research on Human Development, provides new insights into the genetic basis of the complex disorder.In this week's online edition of th... read more »
Source:http://www.medicalnewstoday.com
Discuss   Bury
Guanfacine, a medication commonly prescribed to alleviate symptoms of post-traumatic stress disorder, is no more effective than a placebo, according to a study led by researchers at the San Francisco VA Medical Center."There was no benefit at all, and there were several adverse side effects," says l... read more »
Source:http://www.medicalnewstoday.com
Discuss   Bury
Deal or No Deal - How people might play this popular game show - whether they would likely accept an offer for quick cash or opt to hold out for the chance to take home $1 million - probably has less to do with what could be inside each briefcase than whatâ??s inside each contestantâ??s brain, sugg... read more »
Source:http://www.medicalnewstoday.com
Discuss   Bury
Experiments on mouse models of Alzheimer's disease (AD) suggest that treatment with male sex hormones might slow its progression. The findings, published in The Journal of Neuroscience, provide new insight into the relationship between testosterone loss and AD, which affects 4.5 million Americans. [... read more »
Source:http://www.medicalnewstoday.com
Discuss   Bury
Shire plc (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ) announced today that a single once-daily morning dose of the investigational amphetamine compound SPD465, extended release triple-bead mixed amphetamine salts, designed to reduce symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in [click lin... read more »
Source:http://www.medicalnewstoday.com
Discuss   Bury
Organon has decided to continue with the development of asenapine. This follows on from the decision taken by Organon and Pfizer to discontinue their collaboration in the further development of asenapine, a new drug candidate for the treatment of schizophrenia and acute mania associated with Bipolar... read more »
Source:http://www.medicalnewstoday.com
Discuss   Bury
Using a new form of brain imaging known as diffusion tensor imaging (DTI), researchers in the Center for Cognitive Brain Imaging at Carnegie Mellon University have discovered that the so-called white matter in the brains of people with autism has lower structural integrity than in the brains of norm... read more »
Source:http://www.medicalnewstoday.com
Discuss   Bury
"Shape without form, shade without colour, paralysed force, gesture withoutmotion." In his 1925 poem "The Hollow Men," T.S. Eliot describes people mademiserable by uncertainty and fear. At that time, Mr. Eliot was probablywriting about citizens being alienated from the modern, industrializedworld. B... read more »
Source:http://www.medicalnewstoday.com
Discuss   Bury